nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—kidney cancer—sarcoma	0.738	1	CtDrD
Capecitabine—CES1—larynx—sarcoma	0.00604	0.0961	CbGeAlD
Capecitabine—DPYD—mammary gland—sarcoma	0.00391	0.0622	CbGeAlD
Capecitabine—TYMP—endothelium—sarcoma	0.00281	0.0447	CbGeAlD
Capecitabine—CDA—hematopoietic system—sarcoma	0.00229	0.0365	CbGeAlD
Capecitabine—TYMP—mammary gland—sarcoma	0.00227	0.0361	CbGeAlD
Capecitabine—DPYD—cardiac atrium—sarcoma	0.00181	0.0288	CbGeAlD
Capecitabine—DPYD—uterus—sarcoma	0.0018	0.0286	CbGeAlD
Capecitabine—CDA—lymphoid tissue—sarcoma	0.00161	0.0257	CbGeAlD
Capecitabine—TYMP—myometrium—sarcoma	0.00161	0.0256	CbGeAlD
Capecitabine—DPYD—bone marrow—sarcoma	0.00153	0.0243	CbGeAlD
Capecitabine—CDA—tendon—sarcoma	0.00152	0.0241	CbGeAlD
Capecitabine—CDA—bone marrow—sarcoma	0.00147	0.0234	CbGeAlD
Capecitabine—TYMP—seminal vesicle—sarcoma	0.00145	0.0231	CbGeAlD
Capecitabine—TYMP—hematopoietic system—sarcoma	0.00138	0.022	CbGeAlD
Capecitabine—TYMP—connective tissue—sarcoma	0.00133	0.0212	CbGeAlD
Capecitabine—DPYD—testis—sarcoma	0.00131	0.0208	CbGeAlD
Capecitabine—CDA—testis—sarcoma	0.00126	0.02	CbGeAlD
Capecitabine—DPYD—liver—sarcoma	0.00124	0.0196	CbGeAlD
Capecitabine—TYMP—smooth muscle tissue—sarcoma	0.00122	0.0194	CbGeAlD
Capecitabine—CES1—hematopoietic system—sarcoma	0.00119	0.019	CbGeAlD
Capecitabine—CDA—liver—sarcoma	0.00119	0.0189	CbGeAlD
Capecitabine—TYMS—hematopoietic system—sarcoma	0.00119	0.0189	CbGeAlD
Capecitabine—CES1—connective tissue—sarcoma	0.00115	0.0183	CbGeAlD
Capecitabine—TYMS—connective tissue—sarcoma	0.00114	0.0182	CbGeAlD
Capecitabine—TYMS—Vinorelbine—Vincristine—sarcoma	0.0011	0.372	CbGdCrCtD
Capecitabine—TYMS—Podofilox—Etoposide—sarcoma	0.0011	0.372	CbGdCrCtD
Capecitabine—TYMP—cardiac atrium—sarcoma	0.00105	0.0167	CbGeAlD
Capecitabine—TYMS—smooth muscle tissue—sarcoma	0.00104	0.0166	CbGeAlD
Capecitabine—TYMP—uterus—sarcoma	0.00104	0.0166	CbGeAlD
Capecitabine—TYMS—skin of body—sarcoma	0.00103	0.0164	CbGeAlD
Capecitabine—TYMP—lymphoid tissue—sarcoma	0.000972	0.0155	CbGeAlD
Capecitabine—DPYD—lymph node—sarcoma	0.000947	0.0151	CbGeAlD
Capecitabine—TYMP—tendon—sarcoma	0.000914	0.0145	CbGeAlD
Capecitabine—CDA—lymph node—sarcoma	0.000911	0.0145	CbGeAlD
Capecitabine—TYMP—bone marrow—sarcoma	0.000885	0.0141	CbGeAlD
Capecitabine—CYP2C9—mammary gland—sarcoma	0.000849	0.0135	CbGeAlD
Capecitabine—CES1—lymphoid tissue—sarcoma	0.000839	0.0134	CbGeAlD
Capecitabine—TYMS—lymphoid tissue—sarcoma	0.000834	0.0133	CbGeAlD
Capecitabine—TYMS—tendon—sarcoma	0.000784	0.0125	CbGeAlD
Capecitabine—TYMS—bone marrow—sarcoma	0.00076	0.0121	CbGeAlD
Capecitabine—TYMS—Vinblastine—Vincristine—sarcoma	0.000759	0.256	CbGdCrCtD
Capecitabine—TYMP—testis—sarcoma	0.000757	0.012	CbGeAlD
Capecitabine—TYMP—liver—sarcoma	0.000716	0.0114	CbGeAlD
Capecitabine—CES1—testis—sarcoma	0.000653	0.0104	CbGeAlD
Capecitabine—TYMS—testis—sarcoma	0.000649	0.0103	CbGeAlD
Capecitabine—CES1—liver—sarcoma	0.000618	0.00983	CbGeAlD
Capecitabine—TYMS—liver—sarcoma	0.000614	0.00977	CbGeAlD
Capecitabine—TYMP—lymph node—sarcoma	0.000549	0.00873	CbGeAlD
Capecitabine—CYP2C9—hematopoietic system—sarcoma	0.000517	0.00823	CbGeAlD
Capecitabine—CES1—lymph node—sarcoma	0.000474	0.00753	CbGeAlD
Capecitabine—TYMS—lymph node—sarcoma	0.000471	0.00749	CbGeAlD
Capecitabine—CYP2C9—liver—sarcoma	0.000268	0.00426	CbGeAlD
Capecitabine—Angina pectoris—Doxorubicin—sarcoma	7.49e-05	0.000381	CcSEcCtD
Capecitabine—Hypersensitivity—Mitoxantrone—sarcoma	7.46e-05	0.00038	CcSEcCtD
Capecitabine—Asthenia—Vincristine—sarcoma	7.46e-05	0.00038	CcSEcCtD
Capecitabine—Vomiting—Thiotepa—sarcoma	7.46e-05	0.00038	CcSEcCtD
Capecitabine—Pneumonia—Epirubicin—sarcoma	7.45e-05	0.000379	CcSEcCtD
Capecitabine—Infestation NOS—Epirubicin—sarcoma	7.41e-05	0.000377	CcSEcCtD
Capecitabine—Infestation—Epirubicin—sarcoma	7.41e-05	0.000377	CcSEcCtD
Capecitabine—Vomiting—Dactinomycin—sarcoma	7.4e-05	0.000377	CcSEcCtD
Capecitabine—Rash—Thiotepa—sarcoma	7.4e-05	0.000377	CcSEcCtD
Capecitabine—Bronchitis—Doxorubicin—sarcoma	7.39e-05	0.000376	CcSEcCtD
Capecitabine—Dermatitis—Thiotepa—sarcoma	7.39e-05	0.000376	CcSEcCtD
Capecitabine—Headache—Thiotepa—sarcoma	7.35e-05	0.000374	CcSEcCtD
Capecitabine—Stevens-Johnson syndrome—Epirubicin—sarcoma	7.34e-05	0.000374	CcSEcCtD
Capecitabine—Rash—Dactinomycin—sarcoma	7.34e-05	0.000374	CcSEcCtD
Capecitabine—Decreased appetite—Etoposide—sarcoma	7.33e-05	0.000373	CcSEcCtD
Capecitabine—Pancytopenia—Doxorubicin—sarcoma	7.3e-05	0.000372	CcSEcCtD
Capecitabine—Renal failure—Epirubicin—sarcoma	7.28e-05	0.000371	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Etoposide—sarcoma	7.28e-05	0.00037	CcSEcCtD
Capecitabine—Asthenia—Mitoxantrone—sarcoma	7.27e-05	0.00037	CcSEcCtD
Capecitabine—Fatigue—Etoposide—sarcoma	7.27e-05	0.00037	CcSEcCtD
Capecitabine—Neuropathy peripheral—Epirubicin—sarcoma	7.26e-05	0.00037	CcSEcCtD
Capecitabine—Stomatitis—Epirubicin—sarcoma	7.22e-05	0.000367	CcSEcCtD
Capecitabine—Jaundice—Epirubicin—sarcoma	7.22e-05	0.000367	CcSEcCtD
Capecitabine—Pain—Etoposide—sarcoma	7.21e-05	0.000367	CcSEcCtD
Capecitabine—Constipation—Etoposide—sarcoma	7.21e-05	0.000367	CcSEcCtD
Capecitabine—Conjunctivitis—Epirubicin—sarcoma	7.2e-05	0.000366	CcSEcCtD
Capecitabine—Urinary tract infection—Epirubicin—sarcoma	7.2e-05	0.000366	CcSEcCtD
Capecitabine—Neutropenia—Doxorubicin—sarcoma	7.19e-05	0.000366	CcSEcCtD
Capecitabine—Dysuria—Doxorubicin—sarcoma	7.19e-05	0.000366	CcSEcCtD
Capecitabine—Upper respiratory tract infection—Doxorubicin—sarcoma	7.14e-05	0.000364	CcSEcCtD
Capecitabine—Diarrhoea—Vincristine—sarcoma	7.12e-05	0.000362	CcSEcCtD
Capecitabine—Haematuria—Epirubicin—sarcoma	7.06e-05	0.000359	CcSEcCtD
Capecitabine—Photosensitivity reaction—Doxorubicin—sarcoma	7.02e-05	0.000357	CcSEcCtD
Capecitabine—Hepatobiliary disease—Epirubicin—sarcoma	7.01e-05	0.000357	CcSEcCtD
Capecitabine—Weight increased—Doxorubicin—sarcoma	7e-05	0.000356	CcSEcCtD
Capecitabine—Epistaxis—Epirubicin—sarcoma	6.99e-05	0.000356	CcSEcCtD
Capecitabine—Nausea—Thiotepa—sarcoma	6.97e-05	0.000355	CcSEcCtD
Capecitabine—Weight decreased—Doxorubicin—sarcoma	6.95e-05	0.000354	CcSEcCtD
Capecitabine—Feeling abnormal—Etoposide—sarcoma	6.95e-05	0.000353	CcSEcCtD
Capecitabine—Hyperglycaemia—Doxorubicin—sarcoma	6.93e-05	0.000353	CcSEcCtD
Capecitabine—Diarrhoea—Mitoxantrone—sarcoma	6.93e-05	0.000353	CcSEcCtD
Capecitabine—Nausea—Dactinomycin—sarcoma	6.92e-05	0.000352	CcSEcCtD
Capecitabine—Agranulocytosis—Epirubicin—sarcoma	6.91e-05	0.000352	CcSEcCtD
Capecitabine—Pneumonia—Doxorubicin—sarcoma	6.89e-05	0.000351	CcSEcCtD
Capecitabine—Gastrointestinal pain—Etoposide—sarcoma	6.89e-05	0.000351	CcSEcCtD
Capecitabine—Dizziness—Vincristine—sarcoma	6.88e-05	0.00035	CcSEcCtD
Capecitabine—Infestation NOS—Doxorubicin—sarcoma	6.85e-05	0.000349	CcSEcCtD
Capecitabine—Infestation—Doxorubicin—sarcoma	6.85e-05	0.000349	CcSEcCtD
Capecitabine—Stevens-Johnson syndrome—Doxorubicin—sarcoma	6.79e-05	0.000346	CcSEcCtD
Capecitabine—Bradycardia—Epirubicin—sarcoma	6.77e-05	0.000345	CcSEcCtD
Capecitabine—Renal failure—Doxorubicin—sarcoma	6.74e-05	0.000343	CcSEcCtD
Capecitabine—Neuropathy peripheral—Doxorubicin—sarcoma	6.72e-05	0.000342	CcSEcCtD
Capecitabine—Urticaria—Etoposide—sarcoma	6.7e-05	0.000341	CcSEcCtD
Capecitabine—Haemoglobin—Epirubicin—sarcoma	6.68e-05	0.00034	CcSEcCtD
Capecitabine—Stomatitis—Doxorubicin—sarcoma	6.68e-05	0.00034	CcSEcCtD
Capecitabine—Jaundice—Doxorubicin—sarcoma	6.68e-05	0.00034	CcSEcCtD
Capecitabine—Rhinitis—Epirubicin—sarcoma	6.67e-05	0.000339	CcSEcCtD
Capecitabine—Abdominal pain—Etoposide—sarcoma	6.66e-05	0.000339	CcSEcCtD
Capecitabine—Body temperature increased—Etoposide—sarcoma	6.66e-05	0.000339	CcSEcCtD
Capecitabine—Conjunctivitis—Doxorubicin—sarcoma	6.66e-05	0.000339	CcSEcCtD
Capecitabine—Urinary tract infection—Doxorubicin—sarcoma	6.66e-05	0.000339	CcSEcCtD
Capecitabine—Hepatitis—Epirubicin—sarcoma	6.65e-05	0.000338	CcSEcCtD
Capecitabine—Haemorrhage—Epirubicin—sarcoma	6.65e-05	0.000338	CcSEcCtD
Capecitabine—Hypoaesthesia—Epirubicin—sarcoma	6.62e-05	0.000337	CcSEcCtD
Capecitabine—Vomiting—Vincristine—sarcoma	6.61e-05	0.000337	CcSEcCtD
Capecitabine—Pharyngitis—Epirubicin—sarcoma	6.6e-05	0.000336	CcSEcCtD
Capecitabine—Urinary tract disorder—Epirubicin—sarcoma	6.57e-05	0.000334	CcSEcCtD
Capecitabine—Rash—Vincristine—sarcoma	6.56e-05	0.000334	CcSEcCtD
Capecitabine—Dermatitis—Vincristine—sarcoma	6.55e-05	0.000334	CcSEcCtD
Capecitabine—Oedema peripheral—Epirubicin—sarcoma	6.55e-05	0.000333	CcSEcCtD
Capecitabine—Haematuria—Doxorubicin—sarcoma	6.53e-05	0.000333	CcSEcCtD
Capecitabine—Connective tissue disorder—Epirubicin—sarcoma	6.53e-05	0.000333	CcSEcCtD
Capecitabine—Urethral disorder—Epirubicin—sarcoma	6.52e-05	0.000332	CcSEcCtD
Capecitabine—Headache—Vincristine—sarcoma	6.52e-05	0.000332	CcSEcCtD
Capecitabine—Hepatobiliary disease—Doxorubicin—sarcoma	6.48e-05	0.00033	CcSEcCtD
Capecitabine—Epistaxis—Doxorubicin—sarcoma	6.46e-05	0.000329	CcSEcCtD
Capecitabine—Vomiting—Mitoxantrone—sarcoma	6.44e-05	0.000328	CcSEcCtD
Capecitabine—Visual impairment—Epirubicin—sarcoma	6.41e-05	0.000326	CcSEcCtD
Capecitabine—Agranulocytosis—Doxorubicin—sarcoma	6.4e-05	0.000326	CcSEcCtD
Capecitabine—Rash—Mitoxantrone—sarcoma	6.39e-05	0.000325	CcSEcCtD
Capecitabine—Dermatitis—Mitoxantrone—sarcoma	6.38e-05	0.000325	CcSEcCtD
Capecitabine—Headache—Mitoxantrone—sarcoma	6.35e-05	0.000323	CcSEcCtD
Capecitabine—Erythema multiforme—Epirubicin—sarcoma	6.29e-05	0.00032	CcSEcCtD
Capecitabine—Bradycardia—Doxorubicin—sarcoma	6.26e-05	0.000319	CcSEcCtD
Capecitabine—Eye disorder—Epirubicin—sarcoma	6.21e-05	0.000316	CcSEcCtD
Capecitabine—Hypersensitivity—Etoposide—sarcoma	6.21e-05	0.000316	CcSEcCtD
Capecitabine—Tinnitus—Epirubicin—sarcoma	6.2e-05	0.000316	CcSEcCtD
Capecitabine—Haemoglobin—Doxorubicin—sarcoma	6.18e-05	0.000315	CcSEcCtD
Capecitabine—Nausea—Vincristine—sarcoma	6.18e-05	0.000315	CcSEcCtD
Capecitabine—Flushing—Epirubicin—sarcoma	6.17e-05	0.000314	CcSEcCtD
Capecitabine—Cardiac disorder—Epirubicin—sarcoma	6.17e-05	0.000314	CcSEcCtD
Capecitabine—Rhinitis—Doxorubicin—sarcoma	6.17e-05	0.000314	CcSEcCtD
Capecitabine—Haemorrhage—Doxorubicin—sarcoma	6.15e-05	0.000313	CcSEcCtD
Capecitabine—Hepatitis—Doxorubicin—sarcoma	6.15e-05	0.000313	CcSEcCtD
Capecitabine—Hypoaesthesia—Doxorubicin—sarcoma	6.12e-05	0.000312	CcSEcCtD
Capecitabine—Pharyngitis—Doxorubicin—sarcoma	6.11e-05	0.000311	CcSEcCtD
Capecitabine—Urinary tract disorder—Doxorubicin—sarcoma	6.08e-05	0.000309	CcSEcCtD
Capecitabine—Oedema peripheral—Doxorubicin—sarcoma	6.06e-05	0.000308	CcSEcCtD
Capecitabine—Asthenia—Etoposide—sarcoma	6.05e-05	0.000308	CcSEcCtD
Capecitabine—Connective tissue disorder—Doxorubicin—sarcoma	6.05e-05	0.000308	CcSEcCtD
Capecitabine—Angiopathy—Epirubicin—sarcoma	6.03e-05	0.000307	CcSEcCtD
Capecitabine—Urethral disorder—Doxorubicin—sarcoma	6.03e-05	0.000307	CcSEcCtD
Capecitabine—Nausea—Mitoxantrone—sarcoma	6.02e-05	0.000306	CcSEcCtD
Capecitabine—Immune system disorder—Epirubicin—sarcoma	6.01e-05	0.000306	CcSEcCtD
Capecitabine—Mediastinal disorder—Epirubicin—sarcoma	5.99e-05	0.000305	CcSEcCtD
Capecitabine—Chills—Epirubicin—sarcoma	5.97e-05	0.000304	CcSEcCtD
Capecitabine—Pruritus—Etoposide—sarcoma	5.96e-05	0.000303	CcSEcCtD
Capecitabine—Arrhythmia—Epirubicin—sarcoma	5.94e-05	0.000302	CcSEcCtD
Capecitabine—Visual impairment—Doxorubicin—sarcoma	5.93e-05	0.000302	CcSEcCtD
Capecitabine—Alopecia—Epirubicin—sarcoma	5.88e-05	0.000299	CcSEcCtD
Capecitabine—Mental disorder—Epirubicin—sarcoma	5.83e-05	0.000297	CcSEcCtD
Capecitabine—Erythema multiforme—Doxorubicin—sarcoma	5.82e-05	0.000296	CcSEcCtD
Capecitabine—Erythema—Epirubicin—sarcoma	5.79e-05	0.000295	CcSEcCtD
Capecitabine—Malnutrition—Epirubicin—sarcoma	5.79e-05	0.000295	CcSEcCtD
Capecitabine—Diarrhoea—Etoposide—sarcoma	5.77e-05	0.000293	CcSEcCtD
Capecitabine—Eye disorder—Doxorubicin—sarcoma	5.75e-05	0.000293	CcSEcCtD
Capecitabine—Tinnitus—Doxorubicin—sarcoma	5.74e-05	0.000292	CcSEcCtD
Capecitabine—Flushing—Doxorubicin—sarcoma	5.71e-05	0.000291	CcSEcCtD
Capecitabine—Cardiac disorder—Doxorubicin—sarcoma	5.71e-05	0.000291	CcSEcCtD
Capecitabine—Flatulence—Epirubicin—sarcoma	5.7e-05	0.00029	CcSEcCtD
Capecitabine—Dysgeusia—Epirubicin—sarcoma	5.67e-05	0.000289	CcSEcCtD
Capecitabine—Back pain—Epirubicin—sarcoma	5.6e-05	0.000285	CcSEcCtD
Capecitabine—Angiopathy—Doxorubicin—sarcoma	5.58e-05	0.000284	CcSEcCtD
Capecitabine—Dizziness—Etoposide—sarcoma	5.57e-05	0.000284	CcSEcCtD
Capecitabine—Muscle spasms—Epirubicin—sarcoma	5.57e-05	0.000283	CcSEcCtD
Capecitabine—Immune system disorder—Doxorubicin—sarcoma	5.56e-05	0.000283	CcSEcCtD
Capecitabine—Mediastinal disorder—Doxorubicin—sarcoma	5.55e-05	0.000282	CcSEcCtD
Capecitabine—Chills—Doxorubicin—sarcoma	5.52e-05	0.000281	CcSEcCtD
Capecitabine—Arrhythmia—Doxorubicin—sarcoma	5.5e-05	0.00028	CcSEcCtD
Capecitabine—Vision blurred—Epirubicin—sarcoma	5.46e-05	0.000278	CcSEcCtD
Capecitabine—Alopecia—Doxorubicin—sarcoma	5.44e-05	0.000277	CcSEcCtD
Capecitabine—Mental disorder—Doxorubicin—sarcoma	5.39e-05	0.000274	CcSEcCtD
Capecitabine—Ill-defined disorder—Epirubicin—sarcoma	5.37e-05	0.000273	CcSEcCtD
Capecitabine—Vomiting—Etoposide—sarcoma	5.36e-05	0.000273	CcSEcCtD
Capecitabine—Malnutrition—Doxorubicin—sarcoma	5.36e-05	0.000273	CcSEcCtD
Capecitabine—Erythema—Doxorubicin—sarcoma	5.36e-05	0.000273	CcSEcCtD
Capecitabine—Anaemia—Epirubicin—sarcoma	5.35e-05	0.000272	CcSEcCtD
Capecitabine—Rash—Etoposide—sarcoma	5.31e-05	0.00027	CcSEcCtD
Capecitabine—Dermatitis—Etoposide—sarcoma	5.31e-05	0.00027	CcSEcCtD
Capecitabine—Headache—Etoposide—sarcoma	5.28e-05	0.000269	CcSEcCtD
Capecitabine—Flatulence—Doxorubicin—sarcoma	5.28e-05	0.000269	CcSEcCtD
Capecitabine—Dysgeusia—Doxorubicin—sarcoma	5.24e-05	0.000267	CcSEcCtD
Capecitabine—Malaise—Epirubicin—sarcoma	5.22e-05	0.000266	CcSEcCtD
Capecitabine—Vertigo—Epirubicin—sarcoma	5.2e-05	0.000265	CcSEcCtD
Capecitabine—Syncope—Epirubicin—sarcoma	5.19e-05	0.000264	CcSEcCtD
Capecitabine—Leukopenia—Epirubicin—sarcoma	5.18e-05	0.000264	CcSEcCtD
Capecitabine—Back pain—Doxorubicin—sarcoma	5.18e-05	0.000264	CcSEcCtD
Capecitabine—Muscle spasms—Doxorubicin—sarcoma	5.15e-05	0.000262	CcSEcCtD
Capecitabine—Palpitations—Epirubicin—sarcoma	5.12e-05	0.00026	CcSEcCtD
Capecitabine—Loss of consciousness—Epirubicin—sarcoma	5.09e-05	0.000259	CcSEcCtD
Capecitabine—Cough—Epirubicin—sarcoma	5.05e-05	0.000257	CcSEcCtD
Capecitabine—Vision blurred—Doxorubicin—sarcoma	5.05e-05	0.000257	CcSEcCtD
Capecitabine—Nausea—Etoposide—sarcoma	5.01e-05	0.000255	CcSEcCtD
Capecitabine—Hypertension—Epirubicin—sarcoma	5e-05	0.000254	CcSEcCtD
Capecitabine—Ill-defined disorder—Doxorubicin—sarcoma	4.97e-05	0.000253	CcSEcCtD
Capecitabine—Anaemia—Doxorubicin—sarcoma	4.95e-05	0.000252	CcSEcCtD
Capecitabine—Chest pain—Epirubicin—sarcoma	4.93e-05	0.000251	CcSEcCtD
Capecitabine—Arthralgia—Epirubicin—sarcoma	4.93e-05	0.000251	CcSEcCtD
Capecitabine—Myalgia—Epirubicin—sarcoma	4.93e-05	0.000251	CcSEcCtD
Capecitabine—Anxiety—Epirubicin—sarcoma	4.91e-05	0.00025	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	4.89e-05	0.000249	CcSEcCtD
Capecitabine—Discomfort—Epirubicin—sarcoma	4.87e-05	0.000248	CcSEcCtD
Capecitabine—Malaise—Doxorubicin—sarcoma	4.83e-05	0.000246	CcSEcCtD
Capecitabine—Dry mouth—Epirubicin—sarcoma	4.82e-05	0.000245	CcSEcCtD
Capecitabine—Vertigo—Doxorubicin—sarcoma	4.81e-05	0.000245	CcSEcCtD
Capecitabine—Syncope—Doxorubicin—sarcoma	4.8e-05	0.000244	CcSEcCtD
Capecitabine—Leukopenia—Doxorubicin—sarcoma	4.79e-05	0.000244	CcSEcCtD
Capecitabine—Confusional state—Epirubicin—sarcoma	4.76e-05	0.000242	CcSEcCtD
Capecitabine—Palpitations—Doxorubicin—sarcoma	4.73e-05	0.000241	CcSEcCtD
Capecitabine—Oedema—Epirubicin—sarcoma	4.72e-05	0.00024	CcSEcCtD
Capecitabine—Loss of consciousness—Doxorubicin—sarcoma	4.71e-05	0.00024	CcSEcCtD
Capecitabine—Infection—Epirubicin—sarcoma	4.69e-05	0.000239	CcSEcCtD
Capecitabine—Cough—Doxorubicin—sarcoma	4.67e-05	0.000238	CcSEcCtD
Capecitabine—Shock—Epirubicin—sarcoma	4.65e-05	0.000237	CcSEcCtD
Capecitabine—Nervous system disorder—Epirubicin—sarcoma	4.63e-05	0.000236	CcSEcCtD
Capecitabine—Thrombocytopenia—Epirubicin—sarcoma	4.63e-05	0.000235	CcSEcCtD
Capecitabine—Hypertension—Doxorubicin—sarcoma	4.62e-05	0.000235	CcSEcCtD
Capecitabine—Tachycardia—Epirubicin—sarcoma	4.61e-05	0.000235	CcSEcCtD
Capecitabine—Skin disorder—Epirubicin—sarcoma	4.59e-05	0.000234	CcSEcCtD
Capecitabine—Hyperhidrosis—Epirubicin—sarcoma	4.57e-05	0.000232	CcSEcCtD
Capecitabine—Arthralgia—Doxorubicin—sarcoma	4.56e-05	0.000232	CcSEcCtD
Capecitabine—Chest pain—Doxorubicin—sarcoma	4.56e-05	0.000232	CcSEcCtD
Capecitabine—Myalgia—Doxorubicin—sarcoma	4.56e-05	0.000232	CcSEcCtD
Capecitabine—Anxiety—Doxorubicin—sarcoma	4.54e-05	0.000231	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	4.53e-05	0.00023	CcSEcCtD
Capecitabine—Discomfort—Doxorubicin—sarcoma	4.51e-05	0.000229	CcSEcCtD
Capecitabine—Anorexia—Epirubicin—sarcoma	4.5e-05	0.000229	CcSEcCtD
Capecitabine—Dry mouth—Doxorubicin—sarcoma	4.46e-05	0.000227	CcSEcCtD
Capecitabine—Hypotension—Epirubicin—sarcoma	4.41e-05	0.000225	CcSEcCtD
Capecitabine—Confusional state—Doxorubicin—sarcoma	4.41e-05	0.000224	CcSEcCtD
Capecitabine—Oedema—Doxorubicin—sarcoma	4.37e-05	0.000222	CcSEcCtD
Capecitabine—Infection—Doxorubicin—sarcoma	4.34e-05	0.000221	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Epirubicin—sarcoma	4.3e-05	0.000219	CcSEcCtD
Capecitabine—Shock—Doxorubicin—sarcoma	4.3e-05	0.000219	CcSEcCtD
Capecitabine—Nervous system disorder—Doxorubicin—sarcoma	4.29e-05	0.000218	CcSEcCtD
Capecitabine—Thrombocytopenia—Doxorubicin—sarcoma	4.28e-05	0.000218	CcSEcCtD
Capecitabine—Insomnia—Epirubicin—sarcoma	4.27e-05	0.000217	CcSEcCtD
Capecitabine—Tachycardia—Doxorubicin—sarcoma	4.27e-05	0.000217	CcSEcCtD
Capecitabine—Skin disorder—Doxorubicin—sarcoma	4.25e-05	0.000216	CcSEcCtD
Capecitabine—Paraesthesia—Epirubicin—sarcoma	4.24e-05	0.000216	CcSEcCtD
Capecitabine—Hyperhidrosis—Doxorubicin—sarcoma	4.23e-05	0.000215	CcSEcCtD
Capecitabine—Dyspnoea—Epirubicin—sarcoma	4.21e-05	0.000214	CcSEcCtD
Capecitabine—Anorexia—Doxorubicin—sarcoma	4.17e-05	0.000212	CcSEcCtD
Capecitabine—Dyspepsia—Epirubicin—sarcoma	4.16e-05	0.000212	CcSEcCtD
Capecitabine—Decreased appetite—Epirubicin—sarcoma	4.11e-05	0.000209	CcSEcCtD
Capecitabine—Hypotension—Doxorubicin—sarcoma	4.08e-05	0.000208	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Epirubicin—sarcoma	4.08e-05	0.000208	CcSEcCtD
Capecitabine—Fatigue—Epirubicin—sarcoma	4.07e-05	0.000207	CcSEcCtD
Capecitabine—Pain—Epirubicin—sarcoma	4.04e-05	0.000206	CcSEcCtD
Capecitabine—Constipation—Epirubicin—sarcoma	4.04e-05	0.000206	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Doxorubicin—sarcoma	3.98e-05	0.000203	CcSEcCtD
Capecitabine—Insomnia—Doxorubicin—sarcoma	3.95e-05	0.000201	CcSEcCtD
Capecitabine—Paraesthesia—Doxorubicin—sarcoma	3.93e-05	0.0002	CcSEcCtD
Capecitabine—Dyspnoea—Doxorubicin—sarcoma	3.9e-05	0.000198	CcSEcCtD
Capecitabine—Feeling abnormal—Epirubicin—sarcoma	3.89e-05	0.000198	CcSEcCtD
Capecitabine—Gastrointestinal pain—Epirubicin—sarcoma	3.86e-05	0.000197	CcSEcCtD
Capecitabine—Dyspepsia—Doxorubicin—sarcoma	3.85e-05	0.000196	CcSEcCtD
Capecitabine—Decreased appetite—Doxorubicin—sarcoma	3.8e-05	0.000193	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Doxorubicin—sarcoma	3.77e-05	0.000192	CcSEcCtD
Capecitabine—Fatigue—Doxorubicin—sarcoma	3.77e-05	0.000192	CcSEcCtD
Capecitabine—Urticaria—Epirubicin—sarcoma	3.75e-05	0.000191	CcSEcCtD
Capecitabine—Constipation—Doxorubicin—sarcoma	3.74e-05	0.00019	CcSEcCtD
Capecitabine—Pain—Doxorubicin—sarcoma	3.74e-05	0.00019	CcSEcCtD
Capecitabine—Abdominal pain—Epirubicin—sarcoma	3.73e-05	0.00019	CcSEcCtD
Capecitabine—Body temperature increased—Epirubicin—sarcoma	3.73e-05	0.00019	CcSEcCtD
Capecitabine—Feeling abnormal—Doxorubicin—sarcoma	3.6e-05	0.000183	CcSEcCtD
Capecitabine—Gastrointestinal pain—Doxorubicin—sarcoma	3.57e-05	0.000182	CcSEcCtD
Capecitabine—Hypersensitivity—Epirubicin—sarcoma	3.48e-05	0.000177	CcSEcCtD
Capecitabine—Urticaria—Doxorubicin—sarcoma	3.47e-05	0.000177	CcSEcCtD
Capecitabine—Abdominal pain—Doxorubicin—sarcoma	3.46e-05	0.000176	CcSEcCtD
Capecitabine—Body temperature increased—Doxorubicin—sarcoma	3.46e-05	0.000176	CcSEcCtD
Capecitabine—Asthenia—Epirubicin—sarcoma	3.39e-05	0.000173	CcSEcCtD
Capecitabine—Pruritus—Epirubicin—sarcoma	3.34e-05	0.00017	CcSEcCtD
Capecitabine—Diarrhoea—Epirubicin—sarcoma	3.23e-05	0.000165	CcSEcCtD
Capecitabine—Hypersensitivity—Doxorubicin—sarcoma	3.22e-05	0.000164	CcSEcCtD
Capecitabine—Asthenia—Doxorubicin—sarcoma	3.14e-05	0.00016	CcSEcCtD
Capecitabine—Dizziness—Epirubicin—sarcoma	3.12e-05	0.000159	CcSEcCtD
Capecitabine—Pruritus—Doxorubicin—sarcoma	3.09e-05	0.000157	CcSEcCtD
Capecitabine—Vomiting—Epirubicin—sarcoma	3e-05	0.000153	CcSEcCtD
Capecitabine—Diarrhoea—Doxorubicin—sarcoma	2.99e-05	0.000152	CcSEcCtD
Capecitabine—Rash—Epirubicin—sarcoma	2.98e-05	0.000152	CcSEcCtD
Capecitabine—Dermatitis—Epirubicin—sarcoma	2.98e-05	0.000151	CcSEcCtD
Capecitabine—Headache—Epirubicin—sarcoma	2.96e-05	0.000151	CcSEcCtD
Capecitabine—Dizziness—Doxorubicin—sarcoma	2.89e-05	0.000147	CcSEcCtD
Capecitabine—Nausea—Epirubicin—sarcoma	2.81e-05	0.000143	CcSEcCtD
Capecitabine—Vomiting—Doxorubicin—sarcoma	2.78e-05	0.000141	CcSEcCtD
Capecitabine—Rash—Doxorubicin—sarcoma	2.76e-05	0.00014	CcSEcCtD
Capecitabine—Dermatitis—Doxorubicin—sarcoma	2.75e-05	0.00014	CcSEcCtD
Capecitabine—Headache—Doxorubicin—sarcoma	2.74e-05	0.000139	CcSEcCtD
Capecitabine—Nausea—Doxorubicin—sarcoma	2.6e-05	0.000132	CcSEcCtD
